These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

841 related items for PubMed ID: 16596619

  • 1. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
    Wang Z, Ge L, Wang M, Carr BI.
    J Cell Physiol; 2006 Jul; 208(1):133-40. PubMed ID: 16596619
    [Abstract] [Full Text] [Related]

  • 2. Cdc25A and ERK interaction: EGFR-independent ERK activation by a protein phosphatase Cdc25A inhibitor, compound 5.
    Wang Z, Zhang B, Wang M, Carr BI.
    J Cell Physiol; 2005 Aug; 204(2):437-44. PubMed ID: 15672448
    [Abstract] [Full Text] [Related]

  • 3. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
    Marampon F, Ciccarelli C, Zani BM.
    Mol Cancer; 2006 Aug 09; 5():31. PubMed ID: 16899113
    [Abstract] [Full Text] [Related]

  • 4. Involvement of c-Myc in growth inhibition of Hep 3B human hepatoma cells by a vitamin K analog.
    Ge L, Wang Z, Wang M, Kar S, Carr BI.
    J Hepatol; 2004 Nov 09; 41(5):823-9. PubMed ID: 15519656
    [Abstract] [Full Text] [Related]

  • 5. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT, Klein PJ, Wentz SC, Zeni A, Menze A, Schmidt CM.
    J Pharmacol Exp Ther; 2009 Jun 09; 329(3):1063-70. PubMed ID: 19258520
    [Abstract] [Full Text] [Related]

  • 6. Hepatocyte growth factor enhances protein phosphatase Cdc25A inhibitor compound 5-induced hepatoma cell growth inhibition via Akt-mediated MAPK pathway.
    Wang Z, Wang M, Carr BI.
    J Cell Physiol; 2005 Jun 09; 203(3):510-9. PubMed ID: 15534860
    [Abstract] [Full Text] [Related]

  • 7. Involvement of hepatocyte epidermal growth factor receptor mediated activation of mitogen-activated protein kinase signaling pathways in response to growth inhibition by a novel K vitamin.
    Wang Z, Wang M, Carr BI.
    J Cell Physiol; 2000 Jun 09; 183(3):338-46. PubMed ID: 10797308
    [Abstract] [Full Text] [Related]

  • 8. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
    Kukushkin AN, Abramova MV, Svetlikova SB, Darieva ZA, Pospelova TV, Pospelov VA.
    Oncogene; 2002 Jan 24; 21(5):719-30. PubMed ID: 11850800
    [Abstract] [Full Text] [Related]

  • 9. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
    Ushio K, Hashimoto T, Kitamura N, Tanaka T.
    Mol Cancer Res; 2009 Jul 24; 7(7):1179-88. PubMed ID: 19567783
    [Abstract] [Full Text] [Related]

  • 10. Grb2-associated binder-1 plays a central role in the hepatocyte growth factor enhancement of hepatoma growth inhibition by K vitamin analog compound 5.
    Wang Z, Ge L, Wang M, Carr BI.
    Hepatology; 2007 Dec 24; 46(6):2003-13. PubMed ID: 18046719
    [Abstract] [Full Text] [Related]

  • 11. Activation of extracellular signal-regulated kinase signaling by epidermal growth factor mediates c-Jun activation and p300 recruitment in keratin 16 gene expression.
    Wang YN, Chen YJ, Chang WC.
    Mol Pharmacol; 2006 Jan 24; 69(1):85-98. PubMed ID: 16214953
    [Abstract] [Full Text] [Related]

  • 12. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
    Gilad LA, Bresler T, Gnainsky J, Smirnoff P, Schwartz B.
    J Endocrinol; 2005 Jun 24; 185(3):577-92. PubMed ID: 15930183
    [Abstract] [Full Text] [Related]

  • 13. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
    Buck A, Buchholz M, Wagner M, Adler G, Gress T, Ellenrieder V.
    Mol Cancer Res; 2006 Nov 24; 4(11):861-72. PubMed ID: 17114344
    [Abstract] [Full Text] [Related]

  • 14. Fluorinated Cpd 5, a pure arylating K-vitamin derivative, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating MAPK.
    Kar S, Wang M, Ham SW, Carr BI.
    Biochem Pharmacol; 2006 Nov 15; 72(10):1217-27. PubMed ID: 16930563
    [Abstract] [Full Text] [Related]

  • 15. K vitamins, PTP antagonism, and cell growth arrest.
    Carr BI, Wang Z, Kar S.
    J Cell Physiol; 2002 Dec 15; 193(3):263-74. PubMed ID: 12384979
    [Abstract] [Full Text] [Related]

  • 16. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
    Ciccarelli C, Marampon F, Scoglio A, Mauro A, Giacinti C, De Cesaris P, Zani BM.
    Mol Cancer; 2005 Dec 13; 4():41. PubMed ID: 16351709
    [Abstract] [Full Text] [Related]

  • 17. Fibronectin stimulates human lung carcinoma cell proliferation by suppressing p21 gene expression via signals involving Erk and Rho kinase.
    Han S, Sidell N, Roman J.
    Cancer Lett; 2005 Feb 28; 219(1):71-81. PubMed ID: 15694666
    [Abstract] [Full Text] [Related]

  • 18. Molecular mechanism of cell cycle blockage of hepatoma SK-Hep-1 cells by Epimedin C through suppression of mitogen-activated protein kinase activation and increased expression of CDK inhibitors p21(Cip1) and p27(Kip1).
    Liu TZ, Chen CY, Yiin SJ, Chen CH, Cheng JT, Shih MK, Wang YS, Chern CL.
    Food Chem Toxicol; 2006 Feb 28; 44(2):227-35. PubMed ID: 16112786
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.